Fitusiran lowers antithrombin levels in hemophilia A, B
Fitusiran lowers antithrombin levels in hemophilia A, B
About this item
Full title
Fitusiran lowers antithrombin levels in hemophilia A, B
Author / Creator
Publisher
Thorofare: SLACK INCORPORATED
Journal title
HEM/ONC today, 2018-04, Vol.19 (7), p.52-54
Language
English
Formats
Publication information
Publisher
Thorofare: SLACK INCORPORATED
Subjects
More information
Scope and Contents
Contents
Monthly subcutaneous injections of fitusiran lowered antithrombin levels and increased thrombin generation among patients with hemophilia A or B who did not have inhibitory alloantibodies, according to results of an international phase 1, open-label study published in The New England Journal of Medicine. Standard replacement regimens require two or...
Alternative Titles
Full title
Fitusiran lowers antithrombin levels in hemophilia A, B
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2032444637
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2032444637
Other Identifiers
ISSN
1526-0488
How to access this item
Log in as a Library member
